Cutaneous manifestations of COVID-19.
Dermatol Online J
; 27(1)2021 Jan 15.
Article
in English
| MEDLINE | ID: covidwho-1074062
ABSTRACT
The severe acute respiratory syndrome coronavirus two (SARS-CoV-2), which causes the 2019 coronavirus disease (COVID-19), has infected patients worldwide. Physicians have increasingly identified cutaneous findings as a significant clinical manifestation of COVID-19. In this review, we describe the clinical presentation, onset, duration, associated symptoms, treatment, and outcome of cutaneous manifestations thus far reported to be related to COVID-19. We have included data from 63 studies and subdivided reported cutaneous manifestations into the categories of viral exanthem, urticarial, vesicular, chilblains/chilblains-like, non-chilblains vasculopathy-related, pityriasis rosea-like, erythema multiforme-like, Kawasaki/Kawasaki-like disease, and others. Physicians should be aware of the known common cutaneous manifestations of COVID-19 and future research is required to better understand the pathophysiology and prognosis of each COVID-19-related skin manifestation.
Search on Google
Collection:
International databases
Database:
MEDLINE
Main subject:
Skin Diseases
/
COVID-19
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal subject:
Dermatology
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS